Nonalcoholic fatty liver disease (NAFLD) has consolidated as a major public health problem,
affecting~ 25% of the global population. This percentage is significantly higher in the setting …

The epidemiology of nonalcoholic fatty liver disease goes hand-in-hand with the obesity
pandemic. The pathogenesis of fatty liver has shifted from an hepatocentric view to an …

Nonalcoholic fatty liver disease (NAFLD) affects at least 25% of the global adult population
and is one of the leading causes of cirrhosis and hepatocellular carcinoma (HCC) in western …

A 55-year-old Hispanic woman with a past medical history of obesity, type 2 diabetes,
hypertension, and hyperlipidemia is referred for evaluation of asymptomatic elevation of …

Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to nonalcoholic
steatohepatitis (NASH), leading to fibrosis and potentially cirrhosis, and it is one of the most …

Non-alcoholic fatty liver disease (NAFLD) is a disorder of excessive fat accumulation in the
liver, known as steatosis, without alcohol overconsumption. NAFLD can either manifest as …

As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease throughout the
world. Pathophysiological insights into this disease have recently illustrated that various …

Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of metabolic states ranging
from simple steatosis to inflammation with associated fibrosis to cirrhosis. Though …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western
world and its incidence is increasing rapidly. NAFLD is a spectrum ranging from simple …